Outcomes among Hispanic metastatic breast cancer patients treated with alpelisib and fulvestrant: Single institution retrospective study.
Abstract 967: Real-world transcriptomic biomarkers as replacement for immunohistochemistry and FISH studies in breast cancer
Metastatic Breast Cancer (MBC) at a Tertiary Care Cancer Institute
Abstract P6-08-11: Hyperglycemia in Hispanic MBC patients treated with alpelisib: single institution retrospective study
Differential impact of cognitive computing augmented by real world evidence on novice and expert oncologists
Abstract P4-14-05: Confirmation of the TAILORx 21-gene expression trial using a real world observational database
Oncologists’ Perspectives on Barriers to Effective Communication about Genomic Test Results and Preferences for Communication Aides
Real-world economic value of a 21-gene assay in early-stage breast cancer
Growth factor use and costs in breast cancer patients undergoing adjuvant therapy
Early economic benefits of gene expression profiling using a 21-gene panel among patients with early stage, lymph node negative, hormone receptor positive, her2-neu oncogene negative breast cancer
